AKTX - Akari Therapeutics Announces International Clinical Development Program of Nomacopan for the Potential Treatment of COVID-19 Pneumonia
AKTX - Akari Therapeutcis (AKTX) Announces International Clinical Development Program of Nomacopan for the Potential Treatment of COVID-19 Pneumonia NEW 7:11
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.